Stockscreener 앱 받기
58.65
8.47%
4.58
시간 외 거래:
58.26
-0.39
-0.66%
전일 마감가:
$54.07
열려 있는:
$56
하루 거래량:
3.66M
Relative Volume:
2.20
시가총액:
$7.94B
수익:
$2.51B
순이익/손실:
$185.56M
주가수익비율:
43.77
EPS:
1.34
순현금흐름:
$517.59M
1주 성능:
+11.42%
1개월 성능:
+3.62%
6개월 성능:
-33.06%
1년 성능:
-20.66%
1일 변동 폭
$55.25
$58.90
1주일 범위
$52.56
$58.90
52주 변동 폭
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
명칭
Globus Medical Inc
전화
610-930-1800
주소
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
GMED을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
58.65 | 7.15B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-19 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-30 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-02-10 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Needham | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-28 | 개시 | Wells Fargo | Overweight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-29 | 개시 | Loop Capital | Buy |
| 2021-02-18 | 재개 | Needham | Buy |
| 2020-12-08 | 개시 | Citigroup | Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2020-08-06 | 재확인 | Needham | Buy |
| 2020-08-06 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 개시 | Northland Capital | Market Perform |
| 2020-07-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 재확인 | Needham | Buy |
| 2020-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-12 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 재확인 | Needham | Buy |
| 2019-05-24 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 재확인 | Needham | Buy |
| 2019-02-28 | 업그레이드 | UBS | Neutral → Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 재확인 | Needham | Buy |
| 2018-04-04 | 업그레이드 | Needham | Hold → Buy |
모두보기
Globus Medical Inc 주식(GMED)의 최신 뉴스
Quant Strategy Flags Globus Medical Inc. for EntryWeekly Chart Analysis With Entry Advice Provided - beatles.ru
Globus Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Globus Medical Delivers Strong Q2 Results, Reaffirms 2025 Outlook - MSN
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $66 to $106 - 富途牛牛
Are Investors Undervaluing Globus Medical, Inc. (NYSE:GMED) By 43%? - Yahoo Finance
Globus Medical's Q2 2025 Earnings and Strategic Leadership Shifts: A Blueprint for Sustained Growth - AInvest
Globus Medical Surges 8.47% on $210M Volume as Q2 Sales Hit $745M Propelling It into Top 500 High-Volume Stocks - AInvest
Globus Medical: A Strategic Powerhouse in the Evolving Spine Care Landscape - AInvest
Globus Medical reaffirms $2.8B–$2.9B 2025 sales outlook as integration advances and U.S. Spine momentum builds - MSN
Globus Medical Reiterates $2.8B-$2.9B 2025 Sales Outlook Amid Integration Progress and Growing US Spine Market - AInvest
Globus Medical (GMED) Stock Rises on Better-Than-Expected Q2 ResultsNews and Statistics - IndexBox
How Globus Medical's (GMED) Surge in Net Income and Sales May Reshape Its 2025 Outlook - simplywall.st
Barclays raises Globus Medical stock price target to $106 on margin strength - Investing.com Canada
Globus Medical (GMED) Shares Skyrocket, What You Need To Know - Yahoo Finance
Transcript : Globus Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Globus Medical worldwide sales up 18.4% to USD 745.3M in Q2 2025 - Medical Buyer
Globus Medical (NYSE:GMED) Exceeds Q2 Expectations - TradingView
Globus Medical shares rise 6.90% premarket after Q2 sales, adjusted EPS beat expectations. - AInvest
Globus Medical Inc (GMED) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Globus Medical: Q2 Earnings Snapshot - Greenwich Time
Globus Medical Reports Strong Q2 2025 Growth - TipRanks
Globus Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight - GuruFocus
Globus Medical Q2 Earnings Top Consensus, Revenue Hits $745.3M - AInvest
Globus Medical Outperforms Expectations With Strong Q2 Results - Finimize
Globus Medical's Q2 2025 Earnings Outperformance: A Masterclass in Operational Execution and Strategic Innovation - AInvest
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Globus Medical earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Globus Medical (GMED) Q2 Revenue Up 18% - The Globe and Mail
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Globus Medical Q2 sales, adjusted EPS beat expectations - MarketScreener
Globus Medical Q2 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Reaffirmed - MarketScreener
Globus Medical reports Q2 non-GAAP EPS 86c, consensus 75c - TipRanks
GLOBUS MEDICAL INC SEC 10-Q Report - TradingView
Why Globus Medical Shares Are Under Pressure - TipRanks
Globus Medical Reports Second Quarter 2025 Results - GlobeNewswire
Stay Ahead of the Game With Globus Medical (GMED) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Globus Medical (GMED) Earnings Preview: Key Insights for InvestorsNews and Statistics - IndexBox
Globus Medical (GMED) Q2 Earnings: What To Expect - Yahoo Finance
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years - 富途牛牛
Globus Medical GMED 2025Q2 Earnings Preview Upside Potential Driven by Reaffirmed Revenue Guidance - AInvest
How does Globus Medical Inc. compare to its industry peersGet insider insights into market trends - Jammu Links News
Does Globus Medical Inc. stock perform well during market downturnsMassive profits - Jammu Links News
What are Globus Medical Inc. company’s key revenue driversStrongest growth potential - Jammu Links News
What institutional investors are buying Globus Medical Inc. stockHigh-octane financial growth - jammulinksnews.com
How volatile is Globus Medical Inc. stock compared to the marketInvest confidently with actionable market data - Jammu Links News
When is Globus Medical Inc. stock expected to show significant growth - Jammu Links News
What catalysts could drive Globus Medical Inc. stock higher in 2025Significant capital appreciation - Jammu Links News
Is it the right time to buy Globus Medical Inc. stockTap into rapid wealth building techniques - Jammu Links News
What are the technical indicators suggesting about Globus Medical Inc.Stay ahead with daily expert stock picks - Jammu Links News
What makes Globus Medical Inc. stock price move sharplyExceptional market positioning - Jammu Links News
Globus Medical Inc (GMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):